Breaking News Instant updates and real-time market news.

TSLA

Tesla

$305.85

0.52 (0.17%)

, NKE

Nike

$81.93

2.2 (2.76%)

10:55
08/20/18
08/20
10:55
08/20/18
10:55

Fly Intel: Today's top analyst calls on Wall Street

Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN CUTS TESLA PRICE TARGET: JPMorgan analyst Ryan Brinkman reduced his price target on Underweight-rated Tesla (TSLA) back to $195 from $308, telling investors that he is reverting back to valuing shares on the basis of fundamentals alone. While Brinkman said that Tesla "does appear to be exploring a going private transaction," he believes that such a process appears "much less developed" than he had earlier presumed and is "more along the lines of high level intention," suggesting formal incorporation into his valuation analysis "seems premature." NIKE UPGRADED AT TWO FIRMS: Piper Jaffray analyst Erinn Murphy upgraded Nike (NKE) to Overweight from Neutral and raised her price target for shares to $93 from $72, telling investors she believes the risk profile of owning Nike shares has "considerably diminished" and sees Nike moving from downward EPS revisions to upward revisions supported by a stabilizing North America landscape, strong margin and sales drivers and improving brand momentum. Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains, and gains within the family footwear channel specifically, due to improved product offerings and product flow. He raised his price target to $93 from $78 on Nike shares. QUALCOMM UPGRADED TO BUY: Rosenblatt analyst Jun Zhang upgraded Qualcomm (QCOM) to Buy from Neutral and increased its price target to $70 from $57 citing benefits from 5G smartphone growth over the next few years, Zhang said Qualcomm's 5G RF module is better positioned than their 4G product and should continue to gain share in the high-end market due to MediaTek's smartphone chipset roadmap losing traction. BLOOM ENERGY INITIATIONS ALL OVER MAP: Morgan Stanley analyst Stephen Byrd started Bloom Energy (BE) with an Overweight rating and $30 price target, calling the company "a true disruptor" that is revolutionizing on-site power with its natural gas fuel cell systems. Credit Suisse analyst Michael Weinstein started Bloom Energy with a Neutral rating and $24 price target. After a nearly 80% jump off the $15 IPO, the analyst believes that current pricing captures a fair balance between the risk of executing continued cost reductions and the possible upside from accelerating sales growth once the investment tax credit sunsets in 2023. BofA/Merrill analyst Julien Dumouln-Smith initiated Bloom Energy with an Underperform and $19 price target citing high expectations and execution risks over costs and deployment.

TSLA

Tesla

$305.85

0.52 (0.17%)

NKE

Nike

$81.93

2.2 (2.76%)

QCOM

Qualcomm

$66.08

(0.00%)

BE

Bloom Energy

$22.11

-0.11 (-0.50%)

  • 12

    Sep

  • 29

    Oct

TSLA Tesla
$305.85

0.52 (0.17%)

08/20/18
JPMS
08/20/18
NO CHANGE
Target $195
JPMS
Tesla price target cut to $195 from $308 at JPMorgan
JPMorgan analyst Ryan Brinkman reduced his price target on Underweight-rated Tesla back to $195 from $308, telling investors that he is reverting back to valuing shares on the basis of fundamentals alone. Brinkman says that his interpretation of events leads him to believe that funding was not secured for a going private transaction, nor was there any formal proposal. While Brinkman says that Tesla "does appear to be exploring a going private transaction," he believes that such a process appears "much less developed" than he had earlier presumed and is "more along the lines of high level intention," suggesting formal incorporation into his valuation analysis "seems premature."
08/15/18
VERT
08/15/18
NO CHANGE
VERT
Sell
Goldman involvement with Tesla 'doesn't mean anything,' says Vertical Research
Vertical Research analyst Gordon Johnson said Goldman Sachs (GS) being confirmed as a financial advisor to Tesla's (TSLA) proposed go-private offer "does not mean anything" beyond the "superficial optics" of the carmaker being able to "use Goldman's prestigious name to lend credence to the deal." Goldman is "in it for M&A fees" and agreeing to be an advisor is "not based on any inherent understanding of Tesla's value proposition, nor is it based on Goldman's confidence in Tesla's legal situation with respect to its significant issues surrounding disclosures and SEC involvement," according to Johnson, who maintains a Sell rating on Tesla shares.
08/16/18
BERN
08/16/18
NO CHANGE
Target $325
BERN
Tesla price target raised to $325 after 'taking company private' tweet at Bernstein
Bernstein analyst A.M. Sacconaghi, Jr. raised his price target for Tesla to $325 after Elon Musk shocked investors last week when he tweeted that he was considering a take-private transaction for Tesla at $420 per share, and given the fact that it has been over a year since the analyst last adjusted his price target. Sacconaghi sees the odds of a successful take-private transaction at less than 50%, with downside to about $300 and upside to approximately $400.
08/16/18
EVER
08/16/18
NO CHANGE
Target $301
EVER
In Line
After visiting Tesla's Freemont facility, Evercore ISI says Model 3 'on track'
Evercore ISI analyst George Galliers said he is a bit more positive on Tesla following his trip to the company's Freemont facility, stating that Tesla "seems well on the way" to achieving steady production of 5,000 to 6,000 Model 3 units per week and that reaching 7,000 to 8,000 units per week seems "well within reach." Following the trip, he said the Model 3 looks to be "on track" and while he continues to forecast second half Model 3 production of 123,000 units, Galliers now believes his estimate could be 4%-7% too low. He maintains an In Line rating on Tesla shares with a $301 price target.
NKE Nike
$81.93

2.2 (2.76%)

08/20/18
SUSQ
08/20/18
UPGRADE
SUSQ
Positive
Nike upgraded to Positive from Neutral at Susquehanna
08/20/18
PIPR
08/20/18
UPGRADE
Target $93
PIPR
Overweight
Nike upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Erinn Murphy upgraded Nike to Overweight from Neutral and raised her price target for shares to $93 from $72, telling investors in a research note that she believes the risk profile of owning Nike shares has "considerably diminished" and sees Nike moving from downward EPS revisions to upward revisions supported by a stabilizing North America landscape, strong margin and sales drivers and improving brand momentum. Murphy sees EPS power for 2023 to greater than $5.60/share amid the "extremely healthy" athletic category.
08/20/18
08/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Positive from Neutral at Susquehanna and to Overweight from Neutral at Piper Jaffray. 2. Qualcomm (QCOM) upgraded to Buy from Neutral at Rosenblatt with analyst Jun Zhang citing benefits from 5G smartphone growth over the next few years. 3. Flir Systems (FLIR) upgraded to Outperform from Market Perform at William Blair with analyst Louie DiPalma he believes, in the near-term, Flir's enhanced automation and software capabilities are rendering its sensors more powerful and driving adoption. Additionally, DiPalma believes thermal sensors will be common in autonomous vehicles over the longer term, which could be a major source of long-term upside. 4. RBS (RBS) upgraded to Buy from Neutral at Citi. 5. Terex (TEX) upgraded to Neutral from Underperform at Baird with analyst Mig Dobre citing its recent pullback and multiple compression as well as its upcoming investors day. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/18
SUSQ
08/20/18
UPGRADE
Target $93
SUSQ
Positive
Nike upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains and gains within the family footwear channel. The gains are due to improved product offerings and product flow, putting the company on pace to meet its 2023 $50B revenue target, said Poser. He raised his price target to $93 from $78 on Nike shares.
QCOM Qualcomm
$66.08

(0.00%)

08/20/18
RSBL
08/20/18
UPGRADE
Target $70
RSBL
Buy
Qualcomm upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Jun Zhang upgraded Qualcomm (QCOM) to Buy from Neutral and increased its price target to $70 from $57 citing benefits from 5G smartphone growth over the next few years, Zhang said Qualcomm's 5G RF module is better positioned than their 4G product and should continue to gain share in the high-end market due to MediaTek's smartphone chipset roadmap losing traction. Additionally, Qualcomm should see a signifcant ramp in other products such as finger print sensors and believes Apple (AAPL) may still rely on Qualcomm's 5G modem over Intel's (INTC), the analyst wrote in a note to investors.
08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
BE Bloom Energy
$22.11

-0.11 (-0.50%)

08/20/18
OPCO
08/20/18
INITIATION
OPCO
Perform
Bloom Energy initiated with a Perform at Oppenheimer
Oppenheimer analyst Colin Rusch started coverage of Bloom Energy with a Perform rating. While the analyst sees the potential for the company to be a core solution provider in disrupting the power market and leading to the possibility for multi-decade growth, he sees limited valuation support at current price levels and also sees significant execution in front of Bloom.
08/20/18
FBCO
08/20/18
INITIATION
Target $24
FBCO
Neutral
Bloom Energy initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Weinstein started Bloom Energy with a Neutral rating and $24 price target. After a nearly 80% jump off the $15 IPO, the analyst believes that current pricing captures a fair balance between the risk of executing continued cost reductions and the possible upside from accelerating sales growth once the investment tax credit sunsets in 2023.
08/20/18
COWN
08/20/18
INITIATION
Target $24
COWN
Market Perform
Bloom Energy initiated with a Market Perform at Cowen
Cowen analyst Jeffrey Osborne initiated Bloom Energy with a Market Perform rating as he believes shares are fairly valued and trade at a premium to fuel cell peers. He said he is looking forward to the upcoming product cycle, which should drive down LCOE and expand its total addressable market, which would make him more constructive on the stock. Osborne has a $24 price target on Bloom Energy shares.
08/20/18
08/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tenable Holdings (TENB) initiated with an Outperform at William Blair, a Buy at Stifel, BTIG, and Deutsche Bank, an Equal Weight at Morgan Stanley, as well as a Neutral at JPMorgan. 2. Berry Petroleum (BRY) initiated with an Outperform at Wells Fargo and BMO Capital, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and UBS. 3. Aquestive Therapeutics (AQST) initiated with an Outperform at JMP Securities, BMO Capital, and RBC Capital. 4. Auryn Resources (AUG) initiated with a Buy at H.C. Wainwright. 5. Bloom Energy (BE) initiated with an Overweight at JPMorgan, KeyBanc, and Morgan Stanley, a Market Perform at Cowen, a Perform at Oppenheimer, a Neutral at Credit Suisse and Baird, as well as an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.